Kalaris Therapeutics, Inc. (KLRS) — Working Capital to Net Assets Ratio

Latest as of March 2026: 131.3%

Kalaris Therapeutics, Inc. (KLRS) has a Working Capital to Net Assets ratio of 131.3% as of March 2026. Working capital of $90.00 Million (current assets of $98.08 Million minus current liabilities of $8.08 Million) is measured against net assets of $68.56 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See KLRS cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.

WC/NA Ratio

131.3%
Working Capital / Net Assets

Working Capital

$90.00 Million
USD

Current Assets

$98.08 Million
USD

Current Liabilities

$8.08 Million
USD

Kalaris Therapeutics, Inc. Working Capital to Net Assets (2018–2025)

This chart shows how Kalaris Therapeutics, Inc.'s Working Capital to Net Assets ratio has evolved across 8 annual periods from 2018 to 2025. As of March 2026, the ratio stands at 131.3%, reflecting working capital of $90.00 Million against net assets of $68.56 Million USD. For the complete balance sheet picture, see KLRS asset base.

Annual Working Capital to Net Assets for Kalaris Therapeutics, Inc. (2018–2025)

The table below presents the year-by-year Working Capital to Net Assets ratio for Kalaris Therapeutics, Inc. from 2018 to 2025, covering 8 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check KLRS cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Year WC/NA Ratio Working Capital (USD) Net Assets Current Assets Current Liabilities Change (pp)
2025 138.4% $109.09 Million $78.81 Million $118.81 Million $9.71 Million ▲ +38.4 pp
2024 100.0% $113.31 Million $113.31 Million $118.55 Million $5.24 Million ▲ +98.6 pp
2023 1.4% $-609.00K $-45.02 Million $3.33 Million $3.94 Million ▼ -4.6 pp
2022 5.9% $-1.79 Million $-30.27 Million $3.90 Million $5.69 Million ▼ -89.7 pp
2021 95.7% $215.50 Million $225.27 Million $253.35 Million $37.85 Million ▼ -3.2 pp
2020 98.9% $349.02 Million $353.06 Million $361.32 Million $12.29 Million ▲ +1.7 pp
2019 97.2% $118.21 Million $121.62 Million $127.31 Million $9.11 Million ▼ -2.8 pp
2018 100.0% $21.58 Million $21.58 Million $25.31 Million $3.74 Million
pp = percentage points